UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030399 |
|---|---|
| Receipt number | R000034710 |
| Scientific Title | Phase II study of afatinib for non-small cell lung cancer acquired resistance to osimertinib (North Japan Lung Cancer Study Group 1801) |
| Date of disclosure of the study information | 2017/12/15 |
| Last modified on | 2019/06/16 13:30:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/12/14 19:52:05 | ||
| 2 | Update | 2017/12/16 06:45:10 | Anticipated trial start date |
|
| 3 | Update | 2017/12/16 06:47:44 | Anticipated trial start date |
|
| 4 | Update | 2017/12/16 07:00:06 | Anticipated trial start date |
|
| 5 | Update | 2017/12/17 08:10:27 | Organization Category of Funding Organization |
|
| 6 | Update | 2017/12/27 16:36:38 | Organization |
|
| 7 | Update | 2018/12/15 09:13:33 | Recruitment status |
|
| 8 | Update | 2019/06/16 13:30:30 | Date of IRB Last follow-up date |
